Natural history of epilepsy in argininosuccinic aciduria provides new insights into pathophysiology: A retrospective international study
Epilepsia · 2023
DOI: 10.1111/epi.17596 ↗Kurz gefasst
Fachartikel in der Zeitschrift Epilepsia, 2023. Verfasst von Nour Elkhateeb und 25 weiteren Autor:innen. Beteiligte Einrichtung: Department of Paediatric Metabolic Medicine, Great Ormond Street Hospital for Children NHS Trust, London, UK. Hauptthemen laut MEDLINE: Argininosuccinic Aciduria, Epilepsy. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Medical Research Council, NIHR Great Ormond Street Hospital Biomedical Research Centre.
Abstract (Originalsprache)
Objective
Argininosuccinate lyase (ASL) is integral to the urea cycle, which enables nitrogen wasting and biosynthesis of arginine, a precursor of nitric oxide. Inherited ASL deficiency causes argininosuccinic aciduria, the second most common urea cycle defect and an inherited model of systemic nitric oxide deficiency. Patients present with developmental delay, epilepsy, and movement disorder. Here we aim to characterize epilepsy, a common and neurodebilitating comorbidity in argininosuccinic aciduria.
Methods
We conducted a retrospective study in seven tertiary metabolic centers in the UK, Italy, and Canada from 2020 to 2022, to assess the phenotype of epilepsy in argininosuccinic aciduria and correlate it with clinical, biochemical, radiological, and electroencephalographic data.
Results
Thirty‐seven patients, 1–31 years of age, were included. Twenty‐two patients (60%) presented with epilepsy. The median age at epilepsy onset was 24 months. Generalized tonic‐clonic and focal seizures were most common in early‐onset patients, whereas atypical absences were predominant in late‐onset patients. Seventeen patients (77%) required antiseizure medications and six (27%) had pharmacoresistant epilepsy. Patients with epilepsy presented with a severe neurodebilitating disease with higher rates of speech delay ( p = .04) and autism spectrum disorders ( p = .01) and more frequent arginine supplementation ( p = .01) compared to patients without epilepsy. Neonatal seizures were not associated with a higher risk of developing epilepsy. Biomarkers of ureagenesis did not differ between epileptic and non‐epileptic patients. Epilepsy onset in early infancy ( p = .05) and electroencephalographic background asymmetry ( p = .0007) were significant predictors of partially controlled or refractory epilepsy. Significance Epilepsy in argininosuccinic aciduria is frequent, polymorphic, and associated with more frequent neurodevelopmental comorbidities. We identified prognostic factors for pharmacoresistance in epilepsy. This study does not support defective ureagenesis as prominent in the pathophysiology of epilepsy but suggests a role of central dopamine deficiency. A role of arginine in epileptogenesis was not supported and warrants further studies to assess the potential arginine neurotoxicity in argininosuccinic aciduria.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Paediatric Metabolic Medicine, Great Ormond Street Hospital for Children NHS Trust, London, UK.
- Department of Clinical Genetics, Cambridge University Hospitals, Cambridge, UK.
- Division of Metabolism, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
- Department of Neurophysiology, Great Ormond Street Hospital for Children NHS Trust, London, UK.
- Mark Holland Metabolic Unit, Adult Inherited Metabolic Diseases Department, Salford Royal NHS Foundation Trust, Salford, UK.
- Willink Unit, Manchester Centre for Genomic Medicine, Manchester, UK.
ORCID-Profile: Nour Elkhateeb, Julien Baruteau
Förderung
- Medical Research Council
- NIHR Great Ormond Street Hospital Biomedical Research Centre
Zitieren
APA
Elkhateeb, N., Olivieri, G., Siri, B., Boyd, S., Stepien, K. M., Sharma, R., Morris, A. A. M., Hartley, T., Crowther, L., Grunewald, S., Cleary, M., Mundy, H., Chakrapani, A., Lachmann, R., Murphy, E., Santra, S., Uudelepp, M. L., Yeo, M., Bernhardt, I., …, & Baruteau, J. (2023). Natural history of epilepsy in argininosuccinic aciduria provides new insights into pathophysiology: A retrospective international study. Epilepsia. https://doi.org/10.1111/epi.17596
Vancouver
Elkhateeb N, Olivieri G, Siri B, Boyd S, Stepien KM, Sharma R, et al. Natural history of epilepsy in argininosuccinic aciduria provides new insights into pathophysiology: A retrospective international study. Epilepsia. 2023. doi:10.1111/epi.17596
BibTeX
@article{Elkhateeb2023,
author = {Elkhateeb, Nour and Olivieri, Giorgia and Siri, Barbara and Boyd, Stewart and Stepien, Karolina M and Sharma, Reena and Morris, Andrew A M and Hartley, Thomas and Crowther, Laura and Grunewald, Stephanie and Cleary, Maureen and Mundy, Helen and Chakrapani, Anupam and Lachmann, Robin and Murphy, Elaine and Santra, Saikat and Uudelepp, Mari-Liis and Yeo, Mildrid and Bernhardt, Isaac and Sudakhar, Sniya and Chan, Alicia and Mills, Philippa and Ridout, Debora and Gissen, Paul and Dionisi-Vici, Carlo and Baruteau, Julien},
title = {Natural history of epilepsy in argininosuccinic aciduria provides new insights into pathophysiology: A retrospective international study},
journal = {Epilepsia},
year = {2023},
doi = {10.1111/epi.17596}
}
EUVIMED